Nuclear Medicine
DISIDA
Name:
Disida SN Radiofarma – Tc
Active Principle:
Ácido Disopropiliminodiacetico
Therapeutic Action:
It is indicated to evaluate the bile ducts by scintigraphy and quantify duodenal gastric reflux, assess the functional status of hepatic polygonal cells in case of acute or chronic cholecystitis, liver disease with or without jaundice, complete or incomplete choledochal syndromes, biliary tract atresias, fistulas bile ducts, patency control of biliodigestive anastomoses, gallbladder motor function, suspicion of hepatic hematoma or adenoma.
Nuclear Medicine
DISIDA
Name:
Disida SN Radiofarma – Tc
Active Principle:
Ácido Disopropiliminodiacetico
Therapeutic Action:
It is indicated to evaluate the bile ducts by scintigraphy and quantify duodenal gastric reflux, assess the functional status of hepatic polygonal cells in case of acute or chronic cholecystitis, liver disease with or without jaundice, complete or incomplete choledochal syndromes, biliary tract atresias, fistulas bile ducts, patency control of biliodigestive anastomoses, gallbladder motor function, suspicion of hepatic hematoma or adenoma.
RELATED PRODUCTS
-
123I MIBG BACON (R&D)
123I MIBG BACON (R&D)It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest... -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
IODOSOL 123I (R&D)
IODOSOL 123I (R&D)Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test.

